William Shell

William Elson Shell, M.D., (born September 8, 1942[1]) is an American cardiologist and inventor of weight-loss products. He owns several U.S. patents.[2]

Dr. Shell, is a graduate of the University of Michigan Medical School,[3] following which he served at Keesler Air Force Base.[4] Dr. Shell has been certified in cardiovascular disease and internal medicine by the American Board of Internal Medicine since 1974.[5] Dr. Shell is the CEO, Chief Scientific Officer and a board member at Targeted Medical Pharma, Inc. in Los Angeles, California, a specialty pharmaceutical company that develops and distributes medical food products, as explained by Dr. Shell in a 2012 interview.[6]

Professional Life, Publications, Patents and Product Development

He was part of the team that discovered the cardio specific enzyme CK-MB.[7][8] He treated the singer Andy Gibb (hello HIPPA) for his heart problems in 1985-6,[9] and has been quoted on issues relating to cardiac health.[10]

From 1982-1995, Dr. Shell was a member of the cardiology staff at Cedars of Lebanon Hospital and Mount Sinai Hospital. During his tenure, he planned, directed and implemented the merger of the coronary care unit at Cedars of Lebanon and Mount Sinai Hospital to what is now known as Cedars-Sinai Medical Center in Los Angeles, California. Ultimately he left in disgrace, lost his license for illegal practices, and booted from the hospital. Dr. Shell was also Director of the Cardiac Catheterization Laboratory and Director of Cardiac Rehabilitation. In addition, he participated in the planning, funding and administration of NIH grants and managed a biochemistry research laboratory at Cedars-Sinai Medical Center.[11]

As an entrepreneur, Dr. Shell is the owner of multiple patents governing the processes involved in amino acid based medical food products,[12] electronic billing processes as well as cardiac monitoring technology [13] In 2010, the FDA issued an FDA Warning Letter to Dr. Shell as CEO of Physician Therapeutics concerning the following products: Theracodophen-650 Convenience Pack (Hydrocodone 10 mg, Acetaminophen 650 mg, and Theramine); Strazepam Convenience Pack (Temazepam 15 mg and Sentra PM); Gabazolamine-0.5 Convenience Pack (Alprazolam 0.5 mg and GABAdone); Gaboxetine Convenience Pack (Fluoxetine 10 mg and GABAdone); Trazamine Convenience Pack (Tradazone 50 mg and Sentra PM); Senophylline Convenience Pack (Theophylline 100 mg and Sentra PM); Therapentin-60 (Gabapentin 200 mg and Theramine); Prazolamine (Carisoprodol 350 mg and Theramine); Sentradine (Ranitidine 150 mg and Sentra PM); and Therafeldamine (Piroxicam 20 mg and Theramine)[14] Dr. Shell successfully defended these products listed in the warning letter and subsequently worked with FDA to register these products in their database as well as the NIH Dailymed database.[15] Previous products include the Fat Magnet, a product that uses cellulose to trap fat and bind with it.[16]

Dr. Shell also formulated SeQuester, a "natural nutritional fat sequestrant", which added bile to the fibrous matter, claiming to trap fat and allow it to pass through the digestive system without being absorbed by the body.[17]

Dr. Shell recently published new data regarding the nutritional management of pain using the amino acid based medical food Theramine in the American Journal of Therapeutics.[18] in addition to new data regarding the nutritional management of sleep disorders [19] and the nutritional management of PTSD [20]

References

  1. ↑ https://familysearch.org/pal:/MM9.1.1/KTMD-GMC
  2. ↑ Including: US application 7674482, William E. Shell, Elizabeth Charuvastra, "Method and compositions for potentiating pharmaceuticals with amino acid based medical foods", published 2010-09-10, assigned to Targeted Medical Pharma, Inc. and US application 7585523, William E. Shell, Elizabeth Charuvastra, "Composition and Method to Augment and Sustain Neurotransmitter Production", published 2004-03-04, assigned to Targeted Medical Pharma, Inc..
  3. ↑ https://en.wikipedia.org/wiki/University_of_Michigan_Medical_School#Medical_school
  4. ↑ http://www.4-traders.com/business-leaders/William-Shell-073QW9-E/biography/
  5. ↑ http://www.abim.org/
  6. ↑ Video on YouTube
  7. ↑ Shell, William. "Effects of nonsurgical myocardial reperfusion on plasma creatine kinase kinetics in man". American Heart Journal. Retrieved October 1983. Check date values in: |accessdate= (help)
  8. ↑ Yasmineh, Walid G. "Rate of Decay and Distribution Volume of MB lsoenzyme of Creatine Kinase, Intravenously Injected into the Baboon" (PDF). clinchem.org.
  9. ↑ Levin, Eric (March 28, 1988). "Death of Golden Child". People.
  10. ↑ http://www.nytimes.com/1985/05/21/science/defective-warning-system-tied-to-silent-heart-disease.html
  11. ↑ http://www.tmedpharma.com/leadership.php?bio=William-Shell
  12. ↑ http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2&f=G&l=50&d=PTXT&S1=7,674,482&OS=7,674,482&RS=7,674,482
  13. ↑ http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=targeted&FIELD1=ASNM&co1=AND&TERM2=medical&FIELD2=ASNM&d=PTXT
  14. ↑ http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm208680.htm
  15. ↑ http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09c9f50f-e78a-463f-b6da-49bf64b4ed40
  16. ↑ NCAHF (July–August 1989). "Fat Magnet Trial". National Council Against Health Fraud Newsletter.
  17. ↑ http://community.seattletimes.nwsource.com/archive/?date=19940828&slug=1927433
  18. ↑ http://journals.lww.com/americantherapeutics/pages/results.aspx?txtKeywords=theramine
  19. ↑ http://www.la-press.com/sentra-pm-a-medical-food-and-trazodone-in-the-management-of-sleep-diso-article-a3154
  20. ↑ http://www.la-press.com/administration-of-an-amino-acidbased-regimen-for-the-management-of-aut-article-a4419

External links